You are here
Articles
Posted on Monday, May 19, 2008 - 12:31pm
Brian Druker's original research into developing a way of blocking the protein (BCR/ABL) that drives CML, culminated in the development of a Tyrosine Kinase Inhibitor... namely Glivec/imatinib.
Posted on Sunday, April 27, 2008 - 7:12pm
Medscape Hematology-Oncology
More: American Society of Hematology (ASH) 49th Annual Meeting and ExpositionNew Techniques Enabling a Greater Understanding of the Science and Biology of Leukemia:
An Expert...
Posted on Friday, April 11, 2008 - 3:50pm
EUTOS.
Posted on Thursday, March 27, 2008 - 11:25am
New Research Gives Additional Therapeutic Tools For Even More Effective And Longer Control Of Chronic Myeloid Leukemia
Main Category: Lymphoma / Leukemia
Article Date: 25 Mar 2008
Oregon Health & Science University...
Posted on Wednesday, February 27, 2008 - 10:48am
Update on the situation regarding NICE approval of dasatinib (Sprycel) and nilotinib (Tasigna).
Posted on Saturday, February 16, 2008 - 1:47pm
02/06/2008
Elias Jabbour; Jorge E Cortes; Hady Ghanem; Susan O'Brien; Hagop M Kantarjian
Abstract
Chronic myeloid leukemia (CML) is characterized by the formation of the Philadelphia chromosome and...
Posted on Wednesday, February 6, 2008 - 7:29pm
From The Medscape Journal of Medicine
Webcast Video EditorialsePatients: Engaging Patients in Their Own Care
Posted 01/25/2008
Daniel Z. Sands, MD, MPH
Posted on Wednesday, February 6, 2008 - 7:17pm
New Therapeutic Options in CML and What They Mean for Patients:
An Expert Interview With Dr. Jorge Cortes
Posted on Monday, January 21, 2008 - 7:29pm
BMS Press Release:
Uxbridge, UK. January 21, 2008:
Posted on Friday, January 18, 2008 - 12:28pm
Summary:
Imatinib, or Glivec (Gleevec-USA), is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as...
Posted on Thursday, January 17, 2008 - 7:26pm
The study findings strengthen the hypothesis that domestic use of pesticides may play a role in the etiology of childhood hematopoietic malignancies. The consistency of the findings with those of previous studies on AL...
Posted on Tuesday, January 8, 2008 - 12:52pm
ChemGenex Investigators Report Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients with the T315I Mutation
....more
Posted on Tuesday, January 8, 2008 - 12:32pm
Bosutinib: A New Kinase Inhibitor for Treatment of Philadelphia Chromosome Positive Leukemia
Researchers involved in an international study have reported that bosutinib (SKI606) is a new active kinase inhibitor for the...
Posted on Tuesday, January 8, 2008 - 12:23pm
December 10th 2007
PORTLAND, Ore. - Oregon Health & Science University Cancer Institute researchers have found a new, experimental drug candidate it to be effective against a highly resistant...
Posted on Wednesday, January 2, 2008 - 1:12pm
Report on the 6th CML Patient and Carer Seminar held in Edinburgh on Saturday 24th November 2007
The seminar was held at Houstoun House Hotel which is just outside of Edinburgh and was hosted by Tessa Holyoake from...
- ‹ previous
- 28 of 29
- next ›